Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Jan 11:12:7.
doi: 10.1186/1745-6215-12-7.

Accrual and drop out in a primary prevention randomised controlled trial: qualitative study

Helen C Eborall  1 , Marlene C W Stewart, Sarah Cunningham-Burley, Jackie F Price, F Gerry R Fowkes
Affiliations
Randomized Controlled Trial

Accrual and drop out in a primary prevention randomised controlled trial: qualitative study

Helen C Eborall et al. Trials. .

Abstract

Background: Recruitment and retention of participants are critical to the success of a randomised controlled trial. Gaining the views of potential trial participants who decline to enter a trial and of trial participants who stop the trial treatment is important and can help to improve study processes. Limited research on these issues has been conducted on healthy individuals recruited for prevention trials in the community.

Methods: Semi-structured interviews with people who were eligible but had declined to participate in the Aspirin for Asymptomatic Atherosclerosis (AAA) trial (N = 11), and AAA trial participants who had stopped taking the trial medication (N = 11). A focus group with further participants who had stopped taking the trial medication (N = 6). (Total participants N = 28).

Results: Explanations for declining to participate could be divided into two groups: the first group were characterised by a lack of necessity to participate and a tendency to prioritise other largely mundane problems. The second group's concern was with a high level of perceived risk from participating.Explanations for stopping trial medication fell into four categories: side effects attributed to the trial medication; starting on aspirin or medication contraindicating to aspirin; experiencing an outcome event, and changing one's mind.

Conclusions: These results indicate that when planning trials (especially in preventive medicine) particular attention should be given to designing appropriate recruitment materials and processes that fully inform potential recruits of the risks and benefits of participation.

Trial registration: ISRCTN66587262.

PubMed Disclaimer

References

    1. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357(9263):1191–1194. doi: 10.1016/S0140-6736(00)04337-3. - DOI - PubMed
    1. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663–694. - PubMed
    1. Featherstone K, Donovan J. "Why don't they just tell me straight, why allocate it?" The struggle to make sense of participating in a randomised controlled trial. Soc Sci Med. 2002;55:709–719. doi: 10.1016/S0277-9536(01)00197-6. - DOI - PubMed
    1. Kenyon S, Dixon-Woods M, Jackson C, Windridge K, Pitchforth E. Participating in a trial in a critical situation: a qualitative study in pregnancy. Qual Saf Health Care. 2006;15:98–101. doi: 10.1136/qshc.2005.015636. - DOI - PMC - PubMed
    1. Madsen S, Holm S, Riis P. Attitudes towards clinical research among cancer trial participants and non-participants: an interview study using a grounded theory approach. J Med Ethics. 2007;33:234–240. doi: 10.1136/jme.2005.015255. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data